Gary Jeffrey

Professor Gary Jeffrey is a leading academic in Internal Medicine at the University of Western Australia (UWA) Medical School. His research focuses on liver diseases, including hepatocellular carcinoma, cirrhosis, transplantation, and autoimmune conditions. He has led or contributed to major grants such as the IC3 trial for identifying liver diseases in primary care and projects on predictive models for chronic liver outcomes.

His research interests span gastroenterology and hepatology, addressing clinical management of decompensated cirrhosis, quality of life in cancer therapies, and recurrence patterns post-liver transplant. Key contributions include systematic reviews on hepatocellular carcinoma treatments and multicenter studies on autoimmune liver disease progression.

Professor Jeffrey has been a principal investigator in 7 funded projects since 2008, including NHMRC grants and equipment initiatives. His work aligns with UN Sustainable Development Goals related to health and well-being.

Recent articles emphasize translational research bridging clinical trials, predictive models, and patient-centered outcomes, reflecting his commitment to advancing liver disease management and patient care.